Chapter 1. Depressive Disorders Biomarkers Market - Scope & Methodology
1.1    Market Segmentation
1.2    Assumptions
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources
Chapter 2. Depressive Disorders Biomarkers Market - Executive Summary
2.1    Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
2.3    COVID-19 Impact Analysis
          2.3.1    Impact during 2023 – 2030
          2.3.2    Impact on Supply – Demand
Chapter 3. Depressive Disorders Biomarkers Market - Competition Scenario
3.1    Market Share Analysis
3.2    Product Benchmarking
3.3    Competitive Strategy & Development Scenario
3.4    Competitive Pricing Analysis
3.5    Supplier - Distributor Analysis
Chapter 4. Depressive Disorders Biomarkers Market - Entry Scenario
4.1     Case Studies – Start-up/Thriving Companies
4.2     Regulatory Scenario - By Region
4.3    Customer Analysis
4.4     Porter's Five Force Model
          4.4.1     Bargaining Power of Suppliers
          4.4.2     Bargaining Powers of Customers
          4.4.3    Threat of New Entrants
          4.4.4     Rivalry among Existing Players
          4.4.5    Threat of Substitutes
Chapter 5. Depressive Disorders Biomarkers Market - Landscape
5.1     Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities 
Chapter 6. Depressive Disorders Biomarkers Market - By Type of Biomarkers
6.1    Neurotransmitter Biomarkers
6.2    Genetic Biomarkers
6.3    Imaging Biomarkers
6.4    Others
Chapter 7. Depressive Disorders Biomarkers Market - By End-User
7.1    Hospitals and Clinics
7.2    Pharmaceuticals
7.3    Research Institutes & Laboratories
Chapter 8. Depressive Disorders Biomarkers Market - By Diseases
8.1    Bipolar Disorder
8.2    Postpartum Depression
8.3    Major Depressive Disorder
8.4    Persistent Depressive Disorder
8.5    Others
Chapter 9. Depressive Disorders Biomarkers Market – By Region
9.1    North America
9.2    Europe
9.3    Asia-Pacific
9.4    Latin America
9.5    The Middle East
9.6    Africa
Chapter 10. Depressive Disorders Biomarkers Market – Key players
10.1     Ellipsis Health
10.2    Sonde Health
10.3    Kintsugi Health
10.4    Evocal Health
10.5    Alto Neuroscience
10.6    Biogen Inc
10.7    Sage Therapeutics
10.8    Abbott